article
17 September 2019 | By Dr Gary McLean (Imperial College London and London Metropolitan University), Nikki Withers (Drug Target Review)
Having worked in antibody research for over 20 years, Gary McLean has seen how the industry has progressed and understands the potential that antibodies have in the future of medicine. Nikki Withers hears how the focus has shifted from discovery to genetic sequence manipulation and how this can be applied…